Radiation guidelines for gliomas

被引：4
作者：
Antoni, D. [1 ]
Feuvret, L. [2 ]
Biau, J. [3 ]
Robert, C. [4 ]
Mazeron, J-J [2 ]
Noel, G. [1 ]
机构：
[1] Inst Cancerol Strasbourg Europe ICANS, Serv Radiotherapie, 17 Rue Albert Calmette, F-67200 Strasbourg, France
[2] CHU Pitie Salpetriere, AP HP, Serv Radiotherapie, 47-83 Blvd Hop, F-75013 Paris, France
[3] Unicancer, Dept Univ Radiotherapie, Ctr Jean Perrin, 58 Rue Montalembert,BP 392, F-63011 Clermont Ferrand 01, France
[4] Inst Cancerol Gustave Roussy, Dept Radiotherapie, 39 Rue Camille Desmoulin, F-94800 Villejuif, France
来源：
CANCER RADIOTHERAPIE | 2022年 / 26卷 / 1-2期
关键词：
Recommendations; Glioblastoma; Anaplastic glioma; Diffuse glioma; Biomarkers; Radiation therapy; French society for radiation oncology; LOW-GRADE GLIOMA; INTENSITY-MODULATED RADIOTHERAPY; NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-III TRIAL; QUALITY-OF-LIFE; PROGNOSTIC-FACTOR ANALYSIS; WHOLE-BRAIN RADIOTHERAPY; STEM-CELL COMPARTMENT; ANAPLASTIC OLIGODENDROGLIOMA; EUROPEAN ORGANIZATION;
D O I：
10.1016/j.canrad.2021.08.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gliomas are the most frequent primary brain tumour. The proximity of organs at risk, the infiltrating nature, and the radioresistance of gliomas have to be taken into account in the choice of prescribed dose and technique of radiotherapy. The management of glioma patients is based on clinical factors (age, KPS) and tumour characteristics (histology, molecular biology, tumour location), and strongly depends on available and associated treatments, such as surgery, radiation therapy, and chemotherapy. The knowledge of molecular biomarkers is currently essential, they are increasingly evolving as additional factors that facilitate diagnostics and therapeutic decision-making. We present the update of the recommendations of the French society for radiation oncology on the indications and the technical procedures for performing radiation therapy in patients with gliomas. (C) 2021 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：116 / 128
页数：13
相关论文
共 113 条
  • [1] Glioblastoma Recurrence Patterns After Radiation Therapy With Regard to the Subventricular Zone
    Adeberg, Sebastian
    Koenig, Laila
    Bostel, Tilman
    Harrabi, Semi
    Welzel, Thomas
    Debus, Juergen
    Combs, Stephanie E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (04): : 886 - 893
  • [2] Amichetti Maurizio, 2011, Cancers (Basel), V3, P4061, DOI 10.3390/cancers3044061
  • [3] Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
    Ammirati, Mario
    Chotai, Silky
    Newton, Herbert
    Lamki, Tarig
    Wei, Lai
    Grecula, John
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (04) : 633 - 637
  • [4] Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse
    Antoni, D.
    Jastaniah, Z.
    Haoming, Q. C.
    Gaultier, C.
    Ahle, G.
    Couchot, J.
    Atlani, D.
    Schott, R.
    Claviera, J. -B.
    Srour, R.
    Chaussemy, D.
    Noel, G.
    [J]. CANCER RADIOTHERAPIE, 2016, 20 (04): : 282 - 291
  • [5] Balducci, 1994, Cancer Control, V1, P132
  • [6] Balducci L, 2000, ONCOLOGY-NY, V14, P221
  • [7] Patterns of care for 1,602 patients with newly diagnosed glioblastoma.
    Bauchet, Luc
    Zouaoui, Sonia
    Darlix, Amelie
    Rigau, Valerie
    Mathieu-Daude, Helene
    Fabbro-Peray, Pascale
    Fabbro, Michel
    Pallud, Johan
    Bessaoud, Faiza
    Bauchet, Fabienne
    Charissoux, Marie
    Amelot, Aymeric
    Mandonnet, Emmanuel
    Chinot, Olivier L.
    Figarella-Branger, Dominique
    Labrousse, Francois
    Tretarre, Brigitte
    Taillandier, Luc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
    Baumert, Brigitta G.
    Hegi, Monika E.
    van den Bent, Martin J.
    von Deimling, Andreas
    Gorlia, Thierry
    Hoang-Xuan, Khe
    Brandes, Alba A.
    Kantor, Guy
    Taphoorn, Martin J. B.
    Ben Hassel, Mohamed
    Hartmann, Christian
    Ryan, Gail
    Capper, David
    Kros, Johan M.
    Kurscheid, Sebastian
    Wick, Wolfgang
    Enting, Roelien
    Reni, Michele
    Thiessen, Brian
    Dhermain, Frederic
    Bromberg, Jacoline E.
    Feuvret, Loic
    Reijneveld, Jaap C.
    Chinot, Olivier
    Gijtenbeek, Johanna M. M.
    Rossiter, John P.
    Dif, Nicolas
    Balana, Carmen
    Bravo-Marques, Jose
    Clement, Paul M.
    Marosi, Christine
    Tzuk-Shina, Tzahala
    Nordal, Robert A.
    Rees, Jeremy
    Lacombe, Denis
    Mason, Warren P.
    Stupp, Roger
    [J]. LANCET ONCOLOGY, 2016, 17 (11) : 1521 - 1532
  • [9] Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
    Bell, Erica H.
    Zhang, Peixin
    Shaw, Edward G.
    Buckner, Jan C.
    Barger, Geoffrey R.
    Bullard, Dennis E.
    Mehta, Minesh P.
    Gilbert, Mark R.
    Brown, Paul D.
    Stelzer, Keith J.
    McElroy, Joseph P.
    Fleming, Jessica I.
    Timmers, Cynthia D.
    Becker, Aline P.
    Salavaggione, Andrea L.
    Liu, Ziyan
    Aldape, Kenneth
    Brachman, David G.
    Gertler, Stanley Z.
    Murtha, Albert D.
    Schultz, Christopher J.
    Johnson, David
    Laack, Nadia N.
    Hunter, Grant K.
    Crocker, Ian R.
    Won, Minhee
    Chakravarti, Arnab
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) : 3407 - 3417
  • [10] A MEDICAL-RESEARCH-COUNCIL TRIAL OF 2 RADIOTHERAPY DOSES IN THE TREATMENT OF GRADE-3 AND GRADE-4 ASTROCYTOMA
    BLEEHEN, NM
    STENNING, SP
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (04) : 769 - 774
12345678910